169 related articles for article (PubMed ID: 32769120)
1. An Ultrahigh-Affinity Complement C4b-Specific Nanobody Inhibits In Vivo Assembly of the Classical Pathway Proconvertase.
Zarantonello A; Presumey J; Simoni L; Yalcin E; Fox R; Hansen A; Olesen HG; Thiel S; Johnson MB; Stevens B; Laursen NS; Carroll MC; Andersen GR
J Immunol; 2020 Sep; 205(6):1678-1694. PubMed ID: 32769120
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.
Mortensen S; Kidmose RT; Petersen SV; Szilágyi Á; Prohászka Z; Andersen GR
J Immunol; 2015 Jun; 194(11):5488-96. PubMed ID: 25911760
[TBL] [Abstract][Full Text] [Related]
3. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
Rawal N; Rajagopalan R; Salvi VP
J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
[TBL] [Abstract][Full Text] [Related]
4. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
Thielens NM; Colomb MG
Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted Activities of Seven Nanobodies against Complement C4b.
De la O Becerra KI; Oosterheert W; van den Bos RM; Xenaki KT; Lorent JH; Ruyken M; Schouten A; Rooijakkers SHM; van Bergen En Henegouwen PMP; Gros P
J Immunol; 2022 May; 208(9):2207-2219. PubMed ID: 35428691
[TBL] [Abstract][Full Text] [Related]
6. The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.
Woehl JL; Stapels DAC; Garcia BL; Ramyar KX; Keightley A; Ruyken M; Syriga M; Sfyroera G; Weber AB; Zolkiewski M; Ricklin D; Lambris JD; Rooijakkers SHM; Geisbrecht BV
J Immunol; 2014 Dec; 193(12):6161-6171. PubMed ID: 25381436
[TBL] [Abstract][Full Text] [Related]
7. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
8. A Complement C3-Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity.
Pedersen H; Jensen RK; Jensen JMB; Fox R; Pedersen DV; Olesen HG; Hansen AG; Christiansen D; Mazarakis SMM; Lojek N; Hansen P; Gadeberg TAF; Zarantonello A; Laursen NS; Mollnes TE; Johnson MB; Stevens B; Thiel S; Andersen GR
J Immunol; 2020 Oct; 205(8):2287-2300. PubMed ID: 32938727
[TBL] [Abstract][Full Text] [Related]
9. A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives.
Masaki T; Matsumoto M; Yasuda R; Levine RP; Kitamura H; Seya T
J Immunol; 1991 Aug; 147(3):927-32. PubMed ID: 1861081
[TBL] [Abstract][Full Text] [Related]
10. Formation of high affinity C5 convertase of the classical pathway of complement.
Rawal N; Pangburn MK
J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
[TBL] [Abstract][Full Text] [Related]
11. A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system.
Pedersen H; Jensen RK; Hansen AG; Gadeberg TAF; Thiel S; Laursen NS; Andersen GR
J Biol Chem; 2020 Jun; 295(26):8746-8758. PubMed ID: 32376685
[TBL] [Abstract][Full Text] [Related]
12. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).
Rawal N; Rajagopalan R; Salvi VP
Mol Immunol; 2009 Sep; 46(15):2902-10. PubMed ID: 19660812
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
14. On the site of C4 deposition upon complement activation via the mannan-binding lectin pathway or the classical pathway.
Møller-Kristensen M; Thiel S; Hansen AG; Jensenius JC
Scand J Immunol; 2003 Jun; 57(6):556-61. PubMed ID: 12791093
[TBL] [Abstract][Full Text] [Related]
15. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
[TBL] [Abstract][Full Text] [Related]
16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
17. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
[TBL] [Abstract][Full Text] [Related]
18. A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement.
Jensen RK; Pihl R; Gadeberg TAF; Jensen JK; Andersen KR; Thiel S; Laursen NS; Andersen GR
J Biol Chem; 2018 Apr; 293(17):6269-6281. PubMed ID: 29497000
[TBL] [Abstract][Full Text] [Related]
19. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
20. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
Ebanks RO; Isenman DE
Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
